These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 25482739)

  • 1. Introduction to the updated Australian and New Zealand consensus guidelines for the use of antifungal agents in the haematology/oncology setting, 2014.
    Slavin MA; Thursky KA; Worth LJ; Chang CC; Morrissey CO; Blyth CC; Chen SC; Szer J
    Intern Med J; 2014 Dec; 44(12b):1267-76. PubMed ID: 25482739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Introduction to the updated Australian and New Zealand consensus guidelines for the use of antifungal agents in the haematology/oncology setting, 2008.
    Slavin MA
    Intern Med J; 2008 Jun; 38(6b):457-67. PubMed ID: 18588519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survey of antifungal prophylaxis and fungal diagnostic tests employed in malignant haematology and haemopoietic stem cell transplantation (HSCT) in Australia and New Zealand.
    van Hal SJ; Gilroy NM; Morrissey CO; Worth LJ; Szer J; Tam CS; Chen SC; Thursky KA; Slavin MA
    Intern Med J; 2014 Dec; 44(12b):1277-82. PubMed ID: 25482740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Consensus guidelines for the treatment of yeast infections in the haematology, oncology and intensive care setting, 2014.
    Chen SC; Sorrell TC; Chang CC; Paige EK; Bryant PA; Slavin MA
    Intern Med J; 2014 Dec; 44(12b):1315-32. PubMed ID: 25482743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antifungal prophylaxis during treatment for haematological malignancies: are we there yet?
    Rogers TR; Slavin MA; Donnelly JP
    Br J Haematol; 2011 Jun; 153(6):681-97. PubMed ID: 21504422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Consensus guidelines for the treatment of invasive mould infections in haematological malignancy and haemopoietic stem cell transplantation, 2014.
    Blyth CC; Gilroy NM; Guy SD; Chambers ST; Cheong EY; Gottlieb T; McGuinness SL; Thursky KA
    Intern Med J; 2014 Dec; 44(12b):1333-49. PubMed ID: 25482744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacist review of high-risk haematology outpatients to improve appropriateness of antifungal prophylaxis.
    Reslan Z; Lindsay J; Kerridge I; Gellatly R
    Int J Clin Pharm; 2020 Dec; 42(6):1412-1418. PubMed ID: 33009604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ahead of consensus: a paediatric antifungal prophylaxis census.
    Osowicki J; Blyth CC; Britton PN; Clark J; Cooper CM; Haeusler GM; McMullan B; Bryant PA
    Intern Med J; 2015 Mar; 45(3):364-5. PubMed ID: 25735586
    [No Abstract]   [Full Text] [Related]  

  • 9. [Pocket guide to invasive mycoses in onco-hematologic patients].
    Bermúdez A; Carreras E; De la Cámara R; Eraso E; Fortún J; García-Ruiz JC; Guarro J; Jarque I; Marcos de Lucas E; Mayayo E; Pastor FJ; Pemán J; Pontón J; Quindós G; Salavert M; Sanz MA; Zaragoza R
    Rev Iberoam Micol; 2009; Suppl():3-199. PubMed ID: 20143497
    [No Abstract]   [Full Text] [Related]  

  • 10. Consensus guidelines for optimising antifungal drug delivery and monitoring to avoid toxicity and improve outcomes in patients with haematological malignancy, 2014.
    Chau MM; Kong DC; van Hal SJ; Urbancic K; Trubiano JA; Cassumbhoy M; Wilkes J; Cooper CM; Roberts JA; Marriott DJ; Worth LJ
    Intern Med J; 2014 Dec; 44(12b):1364-88. PubMed ID: 25482746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recommendations for the treatment of established fungal infections.
    Thursky KA; Playford EG; Seymour JF; Sorrell TC; Ellis DH; Guy SD; Gilroy N; Chu J; Shaw DR
    Intern Med J; 2008 Jun; 38(6b):496-520. PubMed ID: 18588522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Introduction to the updated Australasian consensus guidelines for the management of invasive fungal disease and use of antifungal agents in the haematology/oncology setting, 2021.
    Chang CC; Blyth CC; Chen SC; Khanina A; Morrissey CO; Roberts JA; Thursky KA; Worth LJ; Slavin MA;
    Intern Med J; 2021 Nov; 51 Suppl 7():3-17. PubMed ID: 34937135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of mycoses in patients with hematologic disease and cancer -- review of the literature.
    Ruhnke M; Maschmeyer G
    Eur J Med Res; 2002 May; 7(5):227-35. PubMed ID: 12069913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Mycoses and their treatment in malignant hemopathies].
    Martino P; Girmenia C
    Recenti Prog Med; 1999 Mar; 90(3):160-8. PubMed ID: 10228357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimal use of the newer antifungal agents.
    Helwick C
    Oncology (Williston Park); 2000 Sep; 14(9):1262-4. PubMed ID: 11033823
    [No Abstract]   [Full Text] [Related]  

  • 16. [Management and prevention of invasive fungal infections in haematology].
    Wintenberger C
    Med Mal Infect; 2011 Sep; 41(9):503-7. PubMed ID: 21899968
    [No Abstract]   [Full Text] [Related]  

  • 17. Primary prophylaxis of invasive fungal infections in patients with haematologic malignancies. 2014 update of the recommendations of the Infectious Diseases Working Party of the German Society for Haematology and Oncology.
    Tacke D; Buchheidt D; Karthaus M; Krause SW; Maschmeyer G; Neumann S; Ostermann H; Penack O; Rieger C; Ruhnke M; Sandherr M; Schweer KE; Ullmann AJ; Cornely OA
    Ann Hematol; 2014 Sep; 93(9):1449-56. PubMed ID: 24951122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Updated guidelines for managing fungal diseases in hematology patients.
    Hicheri Y; Toma A; Maury S; Pautas C; Mallek-Kaci H; Cordonnier C
    Expert Rev Anti Infect Ther; 2010 Sep; 8(9):1049-60. PubMed ID: 20818948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Empirical versus preemptive antifungal therapy for high-risk, febrile, neutropenic patients: a randomized, controlled trial.
    Cordonnier C; Pautas C; Maury S; Vekhoff A; Farhat H; Suarez F; Dhédin N; Isnard F; Ades L; Kuhnowski F; Foulet F; Kuentz M; Maison P; Bretagne S; Schwarzinger M
    Clin Infect Dis; 2009 Apr; 48(8):1042-51. PubMed ID: 19281327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current therapeutic approaches to fungal infections in immunocompromised hematological patients.
    Pagano L; Caira M; Valentini CG; Posteraro B; Fianchi L
    Blood Rev; 2010 Mar; 24(2):51-61. PubMed ID: 20056300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.